Research study Program year 2023 Source: CMS Open Payments

Rm-493-034

Research payments

$3,025,040

1,299 payments

Through program year 2023, $3,025,040 in research payments was reported against Rm-493-034, across 1,299 payments, paid by Rhythm Pharmaceuticals, Inc..

Paid by: Rhythm Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$1,770,839	712
2022	Research	$1,254,202	587

Breakdown

Who paid Research payments · program years 2022–2023

Rhythm Pharmaceuticals, Inc. $3,025,040 1,299 payments

Who received the money Research payments · program years 2022–2023

Geisinger Clinic Organisation paid for research $291,588 78 payments
Tens Medical Pc Organisation paid for research $284,275 148 payments
Mayo Clinic Organisation paid for research $236,083 76 payments
Clinical Trials Of Texas INC Organisation paid for research $195,017 58 payments
Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $138,082 40 payments
The Trustees Of Columbia Organisation paid for research $134,807 18 payments
University Of Massachusetts Organisation paid for research $131,572 31 payments
Mississippi Center For Advanced Medicine Pc Organisation paid for research $126,681 57 payments
Baylor College of Medicine RHY Organisation paid for research $124,617 41 payments
Research Institute of Dallas PA Organisation paid for research $121,560 47 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.